Skip to main content
  • Original article
  • Open access
  • Published:

Single-breath diffusion capacity of the lung for carbon monoxide in chronic obstructive pulmonary disease

Abstract

Background

Chronic obstructive pulmonary disease (COPD) is defined by progressive, irreversible airflow limitation and an inflammatory response of the lungs, usually to cigarettesmoke. However, COPD is a heterogenous disease in terms of clinical, physiological, and pathological presentation. The pathological hallmarks of COPD are inflammation of the small airways (bronchiolitis) and destruction of lung parenchyma (emphysema). The functional consequence of these abnormalities is airflow limitation.

Aim of work

The aim of the study was to measure diffusion capacity in different stages of COPD.

Patients and methods

Sixty outpatients with COPD with mild to very severe obstruction were included in the study.

Results

There was a statistically significant negative (inverse) correlation between TLCO%, TLCO/VA, PCO2, and HCO3 and there was a statistically significant positive (direct) correlation between TLCO%, TLCO/VA, PO2, and arterial oxygen saturation. There was a statistically significant positive (direct) correlation between FVC%, FEV1%, FEF25%, FEF50%, FEF75%, TLCO%, and TLCO/VA.

Conclusion

Reduced diffusion capacity of the lung for carbon monoxide plus airflow obstruction together identifies a group of individuals with significantly worse lung function.

References

  1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532–555.

    Article  Google Scholar 

  2. Gibson GJ, Macnee W. Chronic obstructive pulmonary disease: investigations and assessment of severity. Management of chronic obstructive pulmonary disease. Eur Respir Mon 2006; 38:24–40.

    Google Scholar 

  3. Van Lee I, Zanen P, VandenBosch JM, Lammers JW. Pattern of diffusion disturbance related to clinical diagnosis. J Resp Med 2006; 100:101–109.

    Article  Google Scholar 

  4. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2014.

  5. American Thoracic Society. Single breath carbon monoxide diffusing capacity (transfer factor), recommendations for a standard technique – 1995 update. Am Rev Respir Dis 1995; 52:2185–2198.

    Google Scholar 

  6. European Respiratory Society. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Res J 1995; 8:1398–1420.

    Article  Google Scholar 

  7. Clark KD, Wardrobe-Wong N, Elliott JJ, Gill PT, Tait NP, Snashall PD. Patterns of lung disease in a “normal” smoking population: are emphysema and airflow obstruction found together? Chest 2001; 120:743–747.

    Article  CAS  Google Scholar 

  8. Matheson MC, Raven J, Johns DP, Abramsona MJ, Walters EH. Associations between reduced diffusing capacity and airflow obstruction in community-based subjects. Respir Med 2007; 101:1730–1737.

    Article  Google Scholar 

  9. Hegewald MJ. Diffusing capacity clinic. Rev Allerg Immunol 2009; 8:125–2.

    Google Scholar 

  10. Polatlý M, Erdinç M, Erdinç E. The early effect of smoking on spirometry and transfer factor. Environ Res 2001; 86:238–243.

    Article  Google Scholar 

  11. Enright PL, Kaminsky DA. Strategies for screening for chronic obstructive pulmonary disease. Respir Care 2003; 48:1194–1201.

    PubMed  Google Scholar 

  12. Brashier B, Saoji S, Raghupati A, Mandrekar S, Valsa S, Gaikwad S. Correlation between spirometric indices (FEV1, FVC) and lung diffusion values (DLCO) in subjects with varying severity of chronic obstructive pulmonary disease (COPD). Am J Resp Crit Care Med 2007; 173:1326–1334.

    Google Scholar 

  13. Mohsenifar Z, Lee SM, Diaz P, Crine RG, Sciurba F, Ginsburg M, Wise RA. Single-breath diffusing capacity of the lung for carbon monoxide. A predictor of PaO2, maximum work rate, and walking distance in patients with emphysema. Chest 2003; 123:1394–1400.

    Article  Google Scholar 

  14. Knower MT, Dunagan DP, Adair NE, Chin R Jr. Baseline oxygen saturation predicts exercise desaturation below prescription threshold in patients with chronic obstructive pulmonary disease. Arch Intern Med 2001; 161:732–736.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Waleed M. El-Sorougi.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

El-Sorougi, W.M., Fathy, M.M. Single-breath diffusion capacity of the lung for carbon monoxide in chronic obstructive pulmonary disease. Egypt J Bronchol 11, 23–28 (2017). https://doi.org/10.4103/1687-8426.199002

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1687-8426.199002

Keywords